What changed 10-K

Item 5. Market for Registrant’s Common Equity

2022-02-24 compared with 2021-02-25 · 9 added, 2 removed, 11 unchanged (50% of the section changed)

10 unchanged sentences

Purchases of Equity Securities by the Issuer and Affiliated Parties

Selected Consolidated Financial Data

Not applicable.

Stock Performance Graph

The graph below compares the cumulative total stockholder return for the period December 31, 2016 through December 31, 2021 for (i) our common stock, (ii) the Nasdaq Biotechnology Index and (iii) the Nasdaq Composite Index.

The graph assumes an investment of $100 on December 31, 2016 in each of our common stock, the Nasdaq Biotechnology Index and the Nasdaq Composite Index and the reinvestment of dividends, if any, although we have never declared or paid any dividends on our common stock.

The stock price performance shown on the graph below is based on historical data and is not indicative of future stock price performance.

The graph and table below shall not be deemed “soliciting material” or to be “filed” with the SEC for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities under that Section, and shall not be deemed to be

incorporated by reference into any of our filings under the Securities Act or the Exchange Act.

Aclaris Therapeutics, Inc.

Nasdaq Composite Index

Nasdaq Biotechnology Index

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.